Alx Oncology Holdings (ALXO) Current Leases (2021 - 2023)
Alx Oncology Holdings recorded quarterly Current Leases of $777000.0 in Q1 2023, up 2.91% quarter-over-quarter from $755000.0 in Q4 2022, and up 30.37% year-over-year from $596000.0 in Q1 2022.
Alx Oncology Holdings' Current Leases history runs 3 years deep, the most recent figure standing at $777000.0 for Q1 2023.
- In Q1 2023, Current Leases rose 30.37% year-over-year to $777000.0; the TTM figure through Mar 2023 stood at $777000.0 (up 30.37% YoY), while the FY2022 annual figure was $755000.0, up 141.21% from the prior year.
- Current Leases came in at $777000.0 for Q1 2023 at Alx Oncology Holdings, up from $755000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $777000.0 in Q1 2023 to a low of $313000.0 in Q4 2021.
- A 3-year average of $635166.7 and a median of $685000.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases surged 141.21% in 2022 and soared 30.37% in 2023, its largest moves.
- Alx Oncology Holdings' Current Leases stood at $313000.0 in 2021, then soared by 141.21% to $755000.0 in 2022, then rose by 2.91% to $777000.0 in 2023.
- According to Business Quant data, Current Leases over the past three periods registered $777000.0, $755000.0, and $724000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Alx Oncology Holdings | 189.80 Mn | 49.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 777,000.00 |
| Dec 31, 2022 | 755,000.00 |
| Sep 30, 2022 | 724,000.00 |
| Jun 30, 2022 | 646,000.00 |
| Mar 31, 2022 | 596,000.00 |
| Dec 31, 2021 | 313,000.00 |